Literature DB >> 11520009

The contribution of thought-action fusion and thought suppression in the development of obsession-like intrusions in normal participants.

E Rassin1.   

Abstract

Both thought-action fusion (TAF: i.e., a cognitive bias implying an inflated sense of responsibility for one's own thoughts) and thought suppression have been claimed to contribute to the development of obsession-like intrusions. Therefore, it seems plausible that conjunction of these phenomena results in highly intense intrusions. However, possible interactions between TAF and thought suppression have not yet been investigated experimentally. In the current study, healthy volunteers were exposed to a TAF-like intrusion. They were, then, randomly assigned to a suppression (n=21) or non-suppression condition (n=19). Next, visual analogue scales (VASs) were completed measuring anxiety, feelings of responsibility and guilt, urge to neutralise and so on. Contrary to expectation, several VAS scores were lower for participants in the suppression group than for those in the non-suppression group. Hence, it is concluded that thought suppression may, at least in the short term, alleviate discomfort caused by TAF-like intrusions.

Entities:  

Mesh:

Year:  2001        PMID: 11520009     DOI: 10.1016/s0005-7967(00)00075-9

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  3 in total

1.  Thought-shape fusion in anorexia and bulimia nervosa: a comparative experimental study.

Authors:  Myrsini Kostopoulou; Eleftheria Varsou; Anastassios Stalikas
Journal:  Eat Weight Disord       Date:  2013-07-24       Impact factor: 4.652

2.  Thought-Shape Fusion in bulimia nervosa: an experimental investigation.

Authors:  M Kostopoulou; E Varsou; A Stalikas
Journal:  Eat Weight Disord       Date:  2010-11-23       Impact factor: 3.008

3.  A role for the precuneus in thought-action fusion: evidence from participants with significant obsessive-compulsive symptoms.

Authors:  Rhiannon Jones; Joydeep Bhattacharya
Journal:  Neuroimage Clin       Date:  2013-11-28       Impact factor: 4.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.